Please join Wilson Sonsini and Niederer Kraft Frey for a panel featuring Swiss and American venture capitalists and executives who will discuss the differences between investment considerations and VC expectations around scaling and development timelines, as well as how to best navigate them.
Chrystel Gelin
cgelin@wsgr.comMatthew J. Meyer is chief business advisor for life sciences at Wilson Sonsini Goodrich & Rosati. Based in San Francisco, Matthew leads the firm's life science business advisory practice—a newly formed, innovative resource aimed at providing start-up and emerging life sciences companies with business insights, capabilities, and strategies to help them thrive and address some of their most challenging issues.